Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1995; Volume 47,Issue 1
  • You have access
    Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide.
    S E Pedersen
    Molecular Pharmacology January 1995, 47 (1) 1-9;
  • You have access
    Expression and characterization of cloned human bombesin receptors.
    R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
    Molecular Pharmacology January 1995, 47 (1) 10-20;
  • You have access
    A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
    F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
    Molecular Pharmacology January 1995, 47 (1) 21-28;
  • You have access
    Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain.
    P Couceyro and J Douglass
    Molecular Pharmacology January 1995, 47 (1) 29-39;
  • You have access
    Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
    Molecular Pharmacology January 1995, 47 (1) 40-50;
  • You have access
    Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
    Molecular Pharmacology January 1995, 47 (1) 51-56;
  • You have access
    Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
    A Rane, Z Liu, C J Henderson and C R Wolf
    Molecular Pharmacology January 1995, 47 (1) 57-64;
  • You have access
    Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose- type" and "brain-type" glucose transporters in mice.
    P C Liu and F Matsumura
    Molecular Pharmacology January 1995, 47 (1) 65-73;
  • You have access
    Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
    A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
    Molecular Pharmacology January 1995, 47 (1) 74-81;
  • You have access
    A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
    B A Ozenberger and J R Hadcock
    Molecular Pharmacology January 1995, 47 (1) 82-87;
  • You have access
    Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    H Matsui, S Lazareno and N J Birdsall
    Molecular Pharmacology January 1995, 47 (1) 88-98;
  • You have access
    Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
    A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
    Molecular Pharmacology January 1995, 47 (1) 99-103;
  • You have access
    ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3.
    M A Ventura and P Thomopoulos
    Molecular Pharmacology January 1995, 47 (1) 104-114;
  • You have access
    Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
    G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
    Molecular Pharmacology January 1995, 47 (1) 115-120;
  • You have access
    Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
    S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
    Molecular Pharmacology January 1995, 47 (1) 121-130;
  • You have access
    Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
    C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
    Molecular Pharmacology January 1995, 47 (1) 131-139;
  • You have access
    Glutamate-induced destabilization of intracellular calcium concentration homeostasis in cultured cerebellar granule cells: role of mitochondria in calcium buffering.
    L Kiedrowski and E Costa
    Molecular Pharmacology January 1995, 47 (1) 140-147;
  • You have access
    Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    F Li, N Owens and T A Verdoorn
    Molecular Pharmacology January 1995, 47 (1) 148-154;
  • You have access
    Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    K Meisheri, M Fosset, S Humphrey and M Lazdunski
    Molecular Pharmacology January 1995, 47 (1) 155-163;
  • You have access
    Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
    C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
    Molecular Pharmacology January 1995, 47 (1) 164-171;
  • You have access
    Agonist selectivity for three species of natriuretic peptide receptor-A.
    J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
    Molecular Pharmacology January 1995, 47 (1) 172-180;
  • You have access
    Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
    W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
    Molecular Pharmacology January 1995, 47 (1) 181-190;
  • You have access
    Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons.
    G E Torres, Y Chaput and R Andrade
    Molecular Pharmacology January 1995, 47 (1) 191-197;
  • You have access
    Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
    A A Malayev, D J Nelson and L H Philipson
    Molecular Pharmacology January 1995, 47 (1) 198-205;
  • You have access
    Structural analogs of interleukin-2: a point mutation that facilitates biological response.
    D Z Chang, M L Tasayco and T L Ciardelli
    Molecular Pharmacology January 1995, 47 (1) 206-211;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 1
1 Jan 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics